PANACEA BIOTEC LTD (PANACEABIO) financials

PANACEA BIOTEC LTD (PANACEABIO) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Incorporated in 1984, Panacea Biotec Ltd is a research-based biotechnology company[1]

Market Cap: ₹2,203Cr.
Current Price: ₹360
ROE: -9.98%
ROCE: -3.40%
Book Value: ₹46.5
Dividend Yield: 0.00%
52W High / Low: ₹648/292

In Jun 2026, PANACEA BIOTEC LTD (PANACEABIO) reported sales ₹134.71 Cr and net profit ₹1.39 Cr.

Annual TTM: sales ₹436 Cr, net profit ₹-22 Cr.

Shareholding: Promoters 72.48% (Sep 2026), FIIs 2.75% (Sep 2026), DIIs 2.47% (Sep 2026), Public 22.31% (Sep 2026), No. of Shareholders 32,961% (Sep 2026).

PANACEABIO quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	76.64	108.43	67.90	112.25	90.81	99.31	111.12	134.71
Expenses	69.90	93.04	86.47	115.27	104.51	100.69	110.82	127.41
Operating Profit	6.74	15.39	-18.57	-3.02	-13.70	-1.38	0.30	7.30
OPM %	8.79%	14.19%	-27.35%	-2.69%	-15.09%	-1.39%	0.27%	5.42%
Other Income	3.41	3.32	6.09	4.95	3.61	3.84	5.60	6.06
Interest	3.76	3.85	4.64	6.00	5.93	7.04	6.33	6.89
Depreciation	5.09	5.21	4.91	4.77	4.91	4.89	4.18	4.47
Profit before tax	1.30	9.65	-22.03	-8.84	-20.93	-9.47	-4.61	2.00
Tax %	0.77%	-0.00%	-43.76%	-24.21%	-25.27%	-22.28%	-96.10%	30.50%
Net Profit	1.29	9.65	-12.39	-6.70	-15.64	-7.36	-0.18	1.39
EPS in Rs	0.21	1.57	-2.02	-1.09	-2.55	-1.20	-0.03	0.23
Raw PDF	—	—	—	—	—	—	—	—

PANACEABIO profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	158	344	236	257	360	310	413	436
Expenses	248	343	308	320	345	317	431	443
Operating Profit	-90	0	-73	-63	14	-7	-18	-7
OPM %	-57%	0.1%	-31%	-24%	3.9%	-2.2%	-4.3%	-1.7%
Other Income	-14	21	13	34	25	17	18	19
Interest	5	8	7	10	14	15	25	26
Depreciation	27	27	26	24	21	20	19	18
Profit before tax	-136	-13	-94	-63	4	-26	-44	-33
Tax %	13%	12%	-0%	40%	16%	-42%	-32%	—
Net Profit	-153	-14	-94	-88	4	-15	-30	-22
EPS in Rs	-24.97	-2.36	-15.27	-14.28	0.58	-2.48	-4.88	-3.55
Dividend Payout %	-0%	-0%	-0%	-0%	-0%	-0%	-0%	—

PANACEABIO balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	6	6	6	6	6	6	6	6
Reserves	412	887	502	409	320	323	308	279
Borrowings	689	67	65	84	102	125	228	265
Other Liabilities	335	179	217	263	296	300	327	302
Total Liabilities	1,442	1,138	790	762	724	754	869	852
Fixed Assets	496	499	464	454	435	423	416	417
CWIP	3	4	13	1	28	97	119	131
Investments	3	3	0	0	0	0	0	0
Other Assets	940	633	313	307	260	234	334	303
Total Assets	1,442	1,138	790	762	724	754	869	852

PANACEABIO cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	107	-83	38	-53	-11	33	4	-40
Cash from Investing Activity	-10	-17	-37	40	2	-47	-61	-18
Cash from Financing Activity	-98	109	-7	10	9	13	90	23
Net Cash Flow	-2	10	-6	-3	1	-1	33	-36
Free Cash Flow	102	-69	28	-59	-10	-36	-49	-74
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	-73%	83%	8,010%	71%	15%	247%	-73%	201%

PANACEABIO shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	72.49%	72.48%	72.48%	72.48%	72.48%	72.48%	72.48%	72.48%
FIIs	0.38%	1.16%	0.79%	1.06%	1.36%	1.60%	2.31%	2.75%
DIIs	1.16%	1.49%	1.52%	1.80%	1.85%	1.96%	2.25%	2.47%
Public	25.96%	24.86%	25.20%	24.65%	24.31%	23.96%	22.96%	22.31%
No. of Shareholders	35,446	33,593	34,256	33,593	34,597	32,620	33,532	32,961

PANACEABIO key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	96	41	37	36	17	11	25	27
Inventory Days	203	619	180	421	260	278	541	218
Days Payable	373	847	257	472	289	299	586	231
Cash Conversion Cycle	-74	-188	-39	-15	-12	-10	-21	15
Working Capital Days	-49	892	4	-63	-135	-79	-104	-8
ROCE %	-14%	-8%	-1%	-16%	-13%	4%	-2%	-3%

PANACEABIOUpdated 18 Oct 2026, 4:18

Panacea Biotec Ltd

PANACEABIOUpdated 18 Oct 2026, 4:18

Market Cap

₹2,203Cr.

Current Price

₹360

High / Low

₹648/292

ROE-9.98%

ROCE-3.40%

Book Value₹46.5

Face Value₹1.00

Dividend Yield0.00%

About

Incorporated in 1984, Panacea Biotec Ltd is a research-based biotechnology company[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	89.41	3.46	82.6	3.34	5.4	1.29	0	1.29	0.21
Sep 2023	94.59	3.55	84.63	2.13	5.34	3.2	0	3.2	0.52
Dec 2023	95.23	3.41	88.59	3.05	5.21	1.07	59.81	0.43	0.07
Mar 2024	80.37	3.36	89.61	16.39	5.14	-1.35	1.48	-1.37	-0.22
Jun 2024	56.88	3.21	67.37	3.8	5.08	-14.98	-8.01	-13.78	-2.25
Sep 2024	76.64	3.76	69.9	3.41	5.09	1.3	0.77	1.29	0.21
Dec 2024	108.43	3.85	93.04	3.32	5.21	9.65	0	9.65	1.57
Mar 2025	67.9	4.64	86.47	6.09	4.91	-22.03	-43.76	-12.39	-2.02
Jun 2025	112.25	6	115.27	4.95	4.77	-8.84	-24.21	-6.7	-1.09
Sep 2025	90.81	5.93	104.51	3.61	4.91	-20.93	-25.27	-15.64	-2.55
Dec 2025	99.31	7.04	100.69	3.84	4.89	-9.47	-22.28	-7.36	-1.2
Mar 2026	111.12	6.33	110.82	5.6	4.18	-4.61	-96.1	-0.18	-0.03
Jun 2026	134.71	6.89	127.41	6.06	4.47	2	30.5	1.39	0.23

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	679	93	612	28	66	-63	3	-65	-10.64
Mar 2016	647	115	534	75	71	1	38	1	0.14
Mar 2017	530	104	460	16	66	-84	-14	-73	-11.85
Mar 2018	184	103	192	84	34	-61	17	-72	-11.73
Mar 2019	96	105	243	322	33	37	29	27	4.33
Mar 2020	158	5	248	-14	27	-136	13	-153	-24.97
Mar 2021	344	8	343	21	27	-13	12	-14	-2.36
Mar 2022	236	7	308	13	26	-94	0	-94	-15.27
Mar 2023	257	10	320	34	24	-63	40	-88	-14.28
Mar 2024	360	14	345	25	21	4	16	4	0.58
Mar 2025	310	15	317	17	20	-26	-42	-15	-2.48
Mar 2026	413	25	431	18	19	-44	-32	-30	-4.88
TTM	436	26	443	19	18	-33	—	-22	-3.55

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	72.48%
FIIs	2.75%
DIIs	2.47%
Public	22.31%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Dec 2023	73.59%	0.26%	0.69%	25.46%
Mar 2024	73.59%	0.27%	0.84%	25.3%
Jun 2024	73.47%	0.26%	1.07%	25.21%
Sep 2024	72.87%	0.37%	1.16%	25.6%
Dec 2024	72.49%	0.38%	1.16%	25.96%
Mar 2025	72.48%	1.16%	1.49%	24.86%
Jun 2025	72.48%	0.79%	1.52%	25.2%
Sep 2025	72.48%	1.06%	1.8%	24.65%
Dec 2025	72.48%	1.36%	1.85%	24.31%
Mar 2026	72.48%	1.6%	1.96%	23.96%
Jun 2026	72.48%	2.31%	2.25%	22.96%
Sep 2026	72.48%	2.75%	2.47%	22.31%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	6	517	1031	325	1879	1060	17	395	408	1879
Mar 2016	6	518	1035	248	1807	988	19	395	406	1807
Mar 2017	6	450	1023	303	1782	942	28	345	467	1782
Mar 2018	6	382	970	316	1673	891	37	345	401	1673
Mar 2019	6	412	689	335	1442	496	3	3	940	1442
Mar 2020	6	887	67	179	1138	499	4	3	633	1138
Mar 2021	6	502	65	217	790	464	13	0	313	790
Mar 2022	6	409	84	263	762	454	1	0	307	762
Mar 2023	6	320	102	296	724	435	28	0	260	724
Mar 2024	6	323	125	300	754	423	97	0	234	754
Mar 2025	6	308	228	327	869	416	119	0	334	869
Mar 2026	6	279	265	302	852	417	131	0	303	852

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	45	-29	-11	5
Mar 2016	98	23	-129	-8
Mar 2017	104	-18	-91	-5
Mar 2018	172	-3	-164	6
Mar 2019	107	-10	-98	-2
Mar 2020	-83	-17	109	10
Mar 2021	38	-37	-7	-6
Mar 2022	-53	40	10	-3
Mar 2023	-11	2	9	1
Mar 2024	33	-47	13	-1
Mar 2025	4	-61	90	33
Mar 2026	-40	-18	23	-36

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	54	80	121	283	96	41	37	36	17	11	25	27
Inventory Days	178	233	304	618	203	619	180	421	260	278	541	218
Days Payable	236	295	490	1,002	373	847	257	472	289	299	586	231
Cash Conversion Cycle	-4	17	-65	-102	-74	-188	-39	-15	-12	-10	-21	15
Working Capital Days	-229	-80	-133	-682	-49	892	4	-63	-135	-79	-104	-8
ROCE %	2%	4%	4%	3%	-14%	-8%	-1%	-16%	-13%	4%	-2%	-3%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of PANACEA BIOTEC LTD (PANACEABIO)?

The reported market capitalisation for PANACEA BIOTEC LTD (PANACEABIO) is ₹2,203Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of PANACEABIO?

The current price shown for PANACEA BIOTEC LTD (PANACEABIO) on Fincrux is ₹360 with a 52-week high/low of ₹648/292.

What were PANACEABIO latest quarterly results?

For Jun 2026, PANACEA BIOTEC LTD (PANACEABIO) reported sales ₹134.71 Cr and net profit ₹1.39 Cr (figures in ₹ crore unless noted).

What are PANACEABIO annual sales and net profit?

For TTM, PANACEA BIOTEC LTD (PANACEABIO) shows sales of ₹436 Cr and net profit of ₹-22 Cr on the Fincrux profit & loss statement.

Who owns PANACEA BIOTEC LTD (PANACEABIO)?

Latest shareholding for PANACEA BIOTEC LTD (PANACEABIO) on Fincrux: Promoters 72.48% (Sep 2026), FIIs 2.75% (Sep 2026), DIIs 2.47% (Sep 2026), Public 22.31% (Sep 2026), No. of Shareholders 32,961% (Sep 2026).

Where can I find PANACEA BIOTEC LTD (PANACEABIO) financials?

PANACEA BIOTEC LTD (PANACEABIO) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show PANACEABIO balance sheet and cash flow?

Yes. The PANACEA BIOTEC LTD (PANACEABIO) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 18 October 2026 at 4:18